S

Savara Pharmaceuticals

42 employees

Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection in cystic fibrosis.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
therapeutics
biopharma
pulmonary
Pharmaceutical
drug delivery
lung
inhaler
infectious disease
cystic fibrosis
MRSA
dry-powder
Biopharma
respiratory
dpi
aerosol
biotech

Date founded

2007

Funding rounds raised

Total raised

$20M

from 7 investors over 7 rounds

S

Savara Pharmaceuticals raised $20M on March 1, 2016

Investors: Carthona Capital, Keiretsu Capital, Keiretsu Forum Northwest, Green Park & Golf Ventures and Haas Portman Family Office

S

Savara Pharmaceuticals raised undisclosed on July 30, 2014

Investors: Green Park & Golf Ventures

S

Savara Pharmaceuticals raised undisclosed on March 1, 2013

Investors: Moore Venture Partners

FAQ